← All diseases

Genetic syndromes and other conditions

CHARGE syndrome

A syndrome present from birth that affects many organs. The eyes, the nasal passages, the ears and the heart are often affected. There may be problems with sight and hearing.

Not part of the panel of Türkiye's National Newborn Screening Programme (heel-prick test). Source

This page is translated from the Turkish original.

This disease is followed through the “Genetic syndromes and other conditions” group.

Understanding the disease

This section has not yet been reviewed by a physician. It summarises patient information from sources such as MedlinePlus, Orphanet and the NHS in plain language. The disease can differ from person to person; talk to your doctor about diagnosis and treatment.

What happens in this disease?

Most people have a change in the CHD7 gene. In the womb, this gene controls the switching on and off of other genes. This is why the eyes, nose, ears, heart and nerves develop differently. The name CHARGE comes from the first letters of the common signs in English.

Which symptoms can occur?

The pattern of signs varies from person to person. The following may be seen:

  • A gap in the eye, called a coloboma (in most)
  • Narrowing or blockage at the back of the nose, difficulty breathing
  • Mild to severe hearing loss and differently shaped ears
  • Difficulty swallowing, facial weakness (palsy), reduced sense of smell
  • Heart problems
  • Slow growth after infancy and developmental delay
  • Delayed puberty, a small penis and undescended testes in boys
  • Cleft lip or cleft palate

How is it diagnosed?

The doctor considers the diagnosis based on the examination and the typical signs. A genetic test of the CHD7 gene confirms the diagnosis. If the test is negative, a chromosomal microarray or broader genetic tests may be done.

Treatment and care

Many specialists work together; a team approach is very important. Blockage of the nose, heart problems and cleft lip are often corrected with surgery. The gap in the eye cannot be corrected with surgery, but glasses can help. For hearing, a hearing aid or a cochlear implant may be considered. Long-term therapy may be needed for feeding and speech. Education suited to sight and hearing loss is important. The doctor who follows the disease decides which treatment is suitable.

For the family: inheritance and genetic counselling

A CHD7 change is passed on through dominant inheritance. This means one copy is enough. In most children the change is new and no one else in the family is affected. Rarely, it is passed on from an affected parent. Genetic counselling is recommended.

Source: MedlinePlus Genetics: CHARGE syndrome · NORD: CHARGE Syndrome

Key facts

How common is it?
Prevalence: 1-9 per 100 000 (Europe)
How is it inherited?
Autosomal dominant · Unknown
When does it usually start?
Before birth, Newborn period
Gene(s) involved
CHD7

These facts are taken from Orphanet and MedlinePlus records (last checked: October 7, 2026). Frequency values are approximate ranges.

You are not alone: patient associations in Türkiye

Non-profit patient and family organizations in Türkiye working on this disease or disease group. Links are for information; Doktorclub is not affiliated with these organizations and does not endorse them.

We could not find a patient association specific to this disease.

For all rare diseases: Nadir Hastalıklar Federasyonu

Guides related to this disease

  • Rare disease at school · Telling the school, medicines and emergency plan, inclusion and BEP, support education room, absences, LGS/YKS arrangements, peer bullying.

Support and help

Doktorclub does not diagnose, recommend treatments or refer you to hospitals or doctors. These pages are meant to help you talk with your doctor.

News about CHARGE

Clinical trials (ClinicalTrials.gov)

A clinical trial is a regulated study that tests whether a new treatment is safe and whether it works, in patients who volunteer. Most trials look for a certain age, genetic change and health condition. Taking part is voluntary.

This list is not a treatment recommendation. Treatments tested in phase 1–3 trials are investigational (experimental): their efficacy and safety have not yet been proven and they are not approved treatments. Taking part depends on each trial’s criteria and a physician’s assessment; the first step is to talk to the doctor who manages your care.

Questions you can ask your doctor

  • Could this trial be suitable for us?
  • If we take part, how would current treatment and check-ups be affected?
  • Where does the trial take place, and how are travel and accommodation handled?
  • What happens if we want to leave the trial?

ClinicalTrials.gov lists 1 active interventional study for this disease. None is recruiting right now; none has a site in Türkiye. Last checked: October 7, 2026.

Selected records (studies with a site in Türkiye first):

See all studies on ClinicalTrials.gov · Joining clinical trials

Genetic syndromes and other conditions: other news

Medical codes (for talking with your doctor and finding sources)

These codes identify the disease in international classifications and databases. They can help when you talk with your doctor or look for reliable sources.

Orphanet code: ORPHA:138

No separate ICD-11 code; WHO classifies this disease under: 5A61.0

Codes checked against WHO ICD-11 and Orphanet on October 7, 2026.

This page provides general information and does not replace diagnosis or treatment. Talk to your doctor about symptoms, diagnosis and treatment.

The information on these pages is for general information only and does not replace medical advice. Talk to your doctor about diagnosis and treatment decisions. In an emergency in Türkiye, call 112.

Every update is based on an open source and labeled with its level of evidence. No advertising and no drug brand names. Our scientific principles

This page was translated from Turkish by the Doktorclub editorial team.